Skip to content
Save up to 80% on your medications — Fast delivery
Champix
Guaranteed quality
Discreet shipping
Returns

Champix - Varenicline

4 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Varenicline
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Champix is an oral smoking cessation medicine for adults who want to stop smoking. It contains varenicline, a non-nicotine treatment that helps reduce cravings and withdrawal. It works by binding to nicotine receptors in the brain, which makes cigarettes feel less rewarding.

What is it?

Champix is an oral smoking cessation medicine containing varenicline for adults who want to stop smoking. It is a non-nicotine treatment that reduces cravings and eases withdrawal while also lowering the “reward” feeling from cigarettes. Varenicline works by binding to nicotine receptors in the brain, so quitting feels more manageable.

Composition

Varenicline is the active ingredient in Champix. It is often supplied as varenicline tartrate.

Varenicline is not a nicotine product. It is a receptor-targeting therapy.

How to use?

Champix tablets are taken by mouth with water, and a 1-week titration is used to reduce side effects, mainly nausea. The standard maintenance target is 1 mg varenicline twice daily after the titration phase.

  • Days 1–3: 0.5 mg once daily
  • Days 4–7: 0.5 mg twice daily
  • Day 8 onward: 1 mg twice daily
  • A quit date is usually set 1–2 weeks after starting.

Taking Champix after food is a simple trick that often reduces nausea. A full glass of water helps, too.

The first week is adjustment. Sleep can feel odd, and cravings can still show up.

Tablet strengths used in the standard schedule

Phase Tablet strength Typical frequency
Titration week 0.5 mg once daily, then twice daily
Maintenance 1 mg twice daily

Missed dose guidance

Skip the missed dose if it is close to the next one. Do not double up. Doubling increases nausea and vivid dreams without improving quit success.

How does it work?

  • Dose: 0.5 mg tablets orally once daily for days 1-3, then 0.5 mg orally twice daily on days 4-7, then 1 mg orally twice daily from day 8 onward if needed.
  • Frequency: Take it every day; the usual maintenance schedule is 2 times/day.
  • Timing: Swallow with water after food; take the morning dose after breakfast and the evening dose after the evening meal.
  • Duration: Start 1-2 weeks before the quit date and continue for 12 weeks; if smoking cessation is achieved, a second 12-week course may be used.
  • Route: Oral tablets.

Indications

Champix is a smoking cessation drug used to support adults who are working toward stopping cigarettes and other nicotine products. It is used within structured quit plans that include a fixed quit date and follow-up.

Comparison

Champix is a smoking cessation drug with a different approach from nicotine replacement therapies (NRTs). NRTs are nicotine replacement drug options that provide nicotine in controlled doses (patch, gum, lozenge), while Champix is a non-nicotine treatment that targets nicotine receptors.

Zyban (bupropion) is another non-nicotine smoking cessation option. It works on noradrenaline and dopamine pathways, so its side effects and cautions differ from varenicline. “Chantix” is a brand name for varenicline used in some markets; the active ingredient relationship is the key point for comparison. WHO materials on tobacco dependence treatments include both varenicline and nicotine replacement therapies as evidence-based options used with behavioural support. [4]

Option Nicotine-based Core mechanism
Champix (varenicline) No Partial agonist at nicotine receptors; reduces cravings and reduces nicotine “reward”
Nicotine replacement therapies Yes Provides nicotine without smoke toxins; reduces withdrawal
Zyban (bupropion) No Affects noradrenaline/dopamine signalling; reduces cravings in some patients

Choosing between these is usually about tolerability, comorbidities (like seizure risk with bupropion), and past quit attempts. Many clinicians also combine behavioural counselling with whichever pharmacologic tool is chosen, because medication handles withdrawal while counselling handles cues and routines.

Contraindications

  • Known hypersensitivity to varenicline
  • Hypersensitivity to any component of the tablets

Not recommended for

Champix is not a good fit if you have had an allergic reaction to varenicline or any tablet ingredient.

Be extra careful and speak with a clinician first if you are pregnant, breastfeeding, have severe kidney disease, have a history of depression or schizophrenia, or are under 18 years of age.

Side effects

Most side effects are dose-related and tend to be most noticeable during the titration week and early maintenance. The most reported effects include:

  • Nausea
  • Sleep disturbance (insomnia or vivid/strange dreams)
  • Headache
  • Increased appetite
  • Irritability or mood changes

Nicotine withdrawal can mimic side effects. Anxiety, restlessness, low mood, and sleep disruption may come from stopping nicotine rather than from varenicline itself, and the timing can overlap.

Side effects you should treat as urgent

Serious reactions are uncommon, but they matter because they require fast assessment:

  • New or worsening depression, agitation, aggressive behaviour, or suicidal ideation and behaviour
  • Signs of a severe allergic reaction (hypersensitivity), such as swelling of the face, mouth, tongue, lips, gums, throat/larynx, or extremities
  • Chest pain, shortness of breath, or fainting

Neuropsychiatric symptoms have been reported during post-marketing experience in patients attempting to quit smoking with Champix, and suicidal ideation and behaviour can also be a symptom of nicotine withdrawal. Updated Champix labeling focuses on recognising mood or behaviour changes early so the treatment plan can be adjusted safely. [3]

One sentence that helps patients: do not “push through” severe mood changes. Report them promptly.

Common mistakes

The same patterns show up again and again.

  • Stopping after 10–14 days because cravings improved, then relapsing during a stressful week.
  • Taking tablets on an empty stomach, then blaming Champix for nausea and quitting early.
  • Keeping cigarettes around “just in case,” which turns a craving into an immediate lapse.
  • Drinking heavily during the first weeks; lowered inhibition makes “one cigarette” more likely, and sleep gets worse.
  • Ignoring mood changes because they assume it is normal withdrawal, even when the change is intense or escalating.

A small workflow change helps: use phone reminders for the first two weeks, then tie dosing to meals once it feels routine.

Doctor opinions

In clinical practice across smoking cessation clinics, doctors often describe varenicline as a strong option for smokers who have tried patches or gum and still felt constant cravings. They also warn patients that the first week is about tolerability, not instant results, and they set expectations for nausea and vivid dreams so patients do not quit the medicine too soon.

Many prescribers in the UAE align follow-up with MOHAP-aligned tobacco cessation pathways: set a quit date, confirm adherence at week 2, then reassess at weeks 4 and 12. Patients who stay engaged in those early checkpoints tend to do better than patients who “go quiet” once the first cravings settle.

One sentence I use often: treat Champix as a tool, not willpower in a tablet.

Frequently asked questions

Craving reduction can start during the titration week, but the effect is usually clearer once the maintenance dose is reached and taken consistently. Some people feel fewer urges before the quit date; others mainly notice that smoking becomes less satisfying. WHO tobacco dependence guidance (updated 2025) treats medication response as variable and supports combining varenicline with behavioural support. The key is steady dosing rather than testing it with frequent cigarettes.

A planned quit date is part of many varenicline treatment plans, so some people will still smoke during the first 1–2 weeks. What often changes is the “reward” feeling, which can weaken the habit loop. EMA prescribing information (updated 2025) supports setting a target stop date and continuing treatment through the early abstinence period. If you keep smoking heavily beyond the planned quit date, the plan usually needs adjusting rather than simply extending the same routine.

People with a mental health history may still use Champix, but they need closer monitoring for mood and behaviour changes. Neuropsychiatric symptoms have been reported post-marketing in people using varenicline during quit attempts, and suicidal ideation and behaviour can also occur with nicotine withdrawal. FDA safety communications and product labeling updates emphasise prompt assessment if significant mood changes appear. A practical approach is to involve a trusted family member who can flag changes early.

Nausea often improves when doses are taken after meals with water, and it can settle after the body adapts. Vivid dreams and insomnia are common, and many patients do better by taking the evening dose earlier with dinner while keeping the twice-daily schedule consistent. EMA safety information for varenicline lists these as expected adverse effects in many users. If sleep disruption is severe, dose adjustments may be considered by the prescriber.

Yes, and this catches people off guard. The effect of smoking cessation can alter pharmacokinetics for some medicines, which may necessitate dosage adjustment for warfarin or insulin as smoking stops and nicotine exposure drops. This is not a classic Champix interaction; it reflects the body recalibrating after cigarettes are removed. MOHAP tobacco cessation materials used in clinical services commonly include medication review during quit attempts for this reason. Monitoring is most relevant in the first weeks after stopping.

Pregnancy and breastfeeding require an individualised decision where benefits and risks are weighed. For breastfeeding, the decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with Champix depends on the benefits of Champix therapy to the woman and the benefits of breastfeeding to the infant. EMA product information discusses these precautionary principles for varenicline use. Many clinicians prioritise non-pharmacologic support first, then consider medication case by case.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Champix — Comparison with alternatives

Champix

Champix Current Best price Best rated

Active ingredient: Varenicline
1mg
From 552.96 AED
pills
4.1 (4)
Naltrexone

Naltrexone

Active ingredient: Naltrexone
50mg
From 821.76 AED
pills
4.1 (4)

Reviews and Experiences

K
Khalid, 37
Dubai
12 weeks
Verified
I started one week before my quit date. Nausea showed up on day 4, but taking it after lunch and dinner fixed most of it. By week 3, cigarettes tasted pointless and I stopped buying them.
12/02/2025
M
Mariam, 29
Abu Dhabi
8 weeks
Verified
Cravings dropped fast, but the dreams were intense and my sleep was lighter. I paused after two months because I felt irritable at work, and I wanted my doctor to re-check my plan before continuing.
26/03/2025
O
Omar, 45
Sharjah
12 weeks
Verified
I had tried gum before and still smoked with coffee. With Champix, the morning coffee trigger was still there, but smoking didn’t feel rewarding. I gained a little weight, so I added a short evening walk and it stabilised.
08/11/2024
S
Sara, 34
Al Ain
12 weeks
Verified
Week one was the hardest because I expected it to be instant. After the dose increase, nausea came back for a few days. The biggest win was not panicking when cravings hit; they passed quicker than I expected.
19/01/2025

Sources

  1. MOHAP (Ministry of Health and Prevention) (2025). National Tobacco Control Program and Tobacco Cessation Services (public information)
  2. EMA (European Medicines Agency) (2025). Champix (varenicline) — Summary of Product Characteristics (SmPC)
  3. FDA (U.S. Food and Drug Administration) (2025). Varenicline (Chantix) — safety information and prescribing information updates
  4. WHO (World Health Organization) (2025). WHO clinical treatment guideline for tobacco cessation in adults
  5. NHS (National Health Service) (2025). Varenicline: how to take it, side effects, and quit-smoking support
Get our free app Shop faster and track your orders 3.8 · 1,437 reviews Install